Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry by Lauren Banner, Daniel Joffe, Emily Lee, Pierluigi Porcu, Neda Nikbakht

Get full text

Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all? by William Johnson, Anjali Mishra, Adam Binder, Alejandro Gru, Pierluigi Porcu

Get full text

The role of interleukin-15 in the development and treatment of hematological malignancies by Paola Sindaco, Paola Sindaco, Hritisha Pandey, Colleen Isabelle, Nitin Chakravarti, Nitin Chakravarti, Jonathan Edward Brammer, Pierluigi Porcu, Pierluigi Porcu, Anjali Mishra, Anjali Mishra, Anjali Mishra

Get full text

Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma by Colin Thomas, Sameep Thapa, Connor McLaughlin, Molly Halloran, Pierluigi Porcu

Get full text

Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia by Miguel Ruiz, Zachary Braunstein, Eric McLaughlin, Anjali Mishra, Pierluigi Porcu, Jonathan E. Brammer

Get full text

A case series of primary cutaneous B-cell lymphomas with atypical presentations: diagnostic and therapeutic challenges by Emily Correia, Jisun Cha, Shalini Krishnasamy, Megan O’Donnell, Wenyin Shi, Pierluigi Porcu, Neda Nikbakht

Get full text

Recalcitrant Cutaneous Mastocytosis Treated With Genetically Informed Targeted Therapy: A Case Report by Laura Gleason, Volkan Tekmen, Alexa Cohen, Safiyyah Bhatti, Burcu Beksac, Jisun Cha, Pierluigi Porcu, Neda Nikbakht

Get full text

Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoprolifer... by Jennifer Hong, William T. Johnson, Saritha Kartan, Anitha S. Gonsalves, Jonathan M. Fenkel, Jerald Z. Gong, Pierluigi Porcu

Get full text

XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways by Nitin Chakravarti, Amy Boles, Rachel Burzinski, Paola Sindaco, Colleen Isabelle, Kathleen McConnell, Anjali Mishra, Pierluigi Porcu

Get full text

Utility of T-cell immunosequencing in distinguishing mycosis fungoides progression from treatment related cutaneous adverse events by Safiyyah Bhatti, Safiyyah Bhatti, Daniel Joffe, Lauren Banner, Sahithi Talasila, Jenna Mandel, Jason Lee, Pierluigi Porcu, Neda Nikbakht

Get full text

Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor by Laura Gleason, Daniel Joffe, Safiyyah Bhatti, Alexa Cohen, Lauren Banner, Emily Correia, Onder Alpdogan, Pierluigi Porcu, Neda Nikbakht

Get full text

Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma by Ramsay Hafer, Francesco Iadevaia, Thomas Z. Rohan, Teresa Duong, Maria Poluch, Gina Keiffer, Michael Li, Andres Ferber, Luca Laurenti, Alan S. Khoo, Pierluigi Porcu

Get full text

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma by Anita Kumar, Santosha Vardhana, Alison J. Moskowitz, Pierluigi Porcu, Ahmet Dogan, Jason A. Dubovsky, Matthew J. Matasar, Zhigang Zhang, Anas Younes, Steven M. Horwitz

Get full text

Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response t... by Carol Gung, Regina McGuire, Mercy George, Abdullateef Abdulkareem, Katherine A. Belden, Pierluigi Porcu, Ubaldo Martinez-Outschoorn, Adam F. Binder, Inna Chervenova, Onder Alpdogan

Get full text

Implementation of an Outpatient HD-MTX Initiative by Kelsey Sokol, Kelley Yuan, Maria Piddoubny, Ellen Sweeney, Anne Delengowski, Katlin Fendler, Gloria Espinosa, Judith Alberto, Patricia Galanis, Carol Gung, Meghan Stokley, Mercy George, Mary Harris, Ubaldo Martinez-Outschoorn, Onder Alpdogan, Pierluigi Porcu, Adam F. Binder

Get full text

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype by Wyndham H. Wilson, Sin-Ho Jung, Pierluigi Porcu, David Hurd, Jeffrey Johnson, S. Eric Martin, Myron Czuczman, Raymond Lai, Jonathan Said, Amy Chadburn, Dan Jones, Kieron Dunleavy, George Canellos, Andrew D. Zelenetz, Bruce D. Cheson, Eric D. Hsi

Get full text

The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual by Daniel Joffe, BS, Thomas Z. Rohan, BS, Jenna Mandel, BS, Jayson Suriano, BA, Lauren Banner, BS, Alexander Valiga, MD, Pierluigi Porcu, MD, Jerald Z. Gong, MD, Jason B. Lee, MD, Onder Alpdogan, MD, Neda Nikbakht, MD, PhD

Get full text

Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma by Bethany Mundy-Bosse, Nathan Denlinger, Eric McLaughlin, Nitin Chakravarti, Susan Hwang, Li Chen, Hsiaoyin Charlene Mao, David Kline, Youssef Youssef, Rebecca Kohnken, Dean Anthony Lee, Gerard Lozanski, Aharon G. Freud, Pierluigi Porcu, Basem William, Michael A. Caligiuri, Anjali Mishra

Get full text